(Q86627019)

English

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions

scientific article published on 01 February 2015

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

editorial

0 references

title

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

idiopathic pulmonary fibrosis

1 reference

2

Moisés Selman

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

author name string

Ganesh Raghu

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

publication date

1 February 2015

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

published in

American Journal of Respiratory and Critical Care Medicine

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

volume

191

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

issue

3

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

page(s)

252-254

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

retrieved

29 February 2020

Identifiers

DOI

10.1164/RCCM.201411-2044ED

1 reference

stated in

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Europe PubMed Central

PubMed ID

25635489

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25635489%20AND%20SRC:MED&resulttype=core&format=json

(Q86627019)

Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)